ArticleCancer immunology, immunotherapy : CII2026
CAR T cells derived from a novel, high-affinity anti-CLL-1 monoclonal antibody exhibit a significant anti-AML effect.
Shuhei Kida et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.